BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 26621760)

  • 21. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
    Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
    Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN/MMAC1 enhances the growth inhibition by anticancer drugs with downregulation of IGF-II expression in gastric cancer cells.
    Hwang PH; Kim SY; Lee JC; Kim SJ; Yi HK; Lee DY
    Exp Mol Med; 2005 Oct; 37(5):391-8. PubMed ID: 16264263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN.
    Yang TS; Yang XH; Chen X; Wang XD; Hua J; Zhou DL; Zhou B; Song ZS
    FEBS Lett; 2014 Jun; 588(13):2162-9. PubMed ID: 24842611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of function of PTEN alters the relationship between glucose concentration and cell proliferation, increases glycolysis, and sensitizes cells to 2-deoxyglucose.
    Blouin MJ; Zhao Y; Zakikhani M; Algire C; Piura E; Pollak M
    Cancer Lett; 2010 Mar; 289(2):246-53. PubMed ID: 19744772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells.
    Dong CG; Wu WK; Feng SY; Wang XJ; Shao JF; Qiao J
    Int J Oncol; 2012 Sep; 41(3):1005-12. PubMed ID: 22766763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN in brain tumors.
    Haas-Kogan D; Stokoe D
    Expert Rev Neurother; 2008 Apr; 8(4):599-610. PubMed ID: 18416662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.
    Hellawell GO; Turner GD; Davies DR; Poulsom R; Brewster SF; Macaulay VM
    Cancer Res; 2002 May; 62(10):2942-50. PubMed ID: 12019176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas.
    Xu Q; Yuan X; Liu G; Black KL; Yu JS
    Stem Cells; 2008 Dec; 26(12):3018-26. PubMed ID: 18787206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors.
    Mellinghoff IK; Cloughesy TF; Mischel PS
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):378-81. PubMed ID: 17255257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
    Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
    Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular biology of brain metastasis.
    Svokos KA; Salhia B; Toms SA
    Int J Mol Sci; 2014 May; 15(6):9519-30. PubMed ID: 24879524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis.
    Doron H; Pukrop T; Erez N
    Cancer Res; 2019 Feb; 79(3):423-436. PubMed ID: 30679177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain May Prime Metastatic Cell Growth.
    Cancer Discov; 2016 Jan; 6(1):OF2. PubMed ID: 26621760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.
    Zhang L; Zhang S; Yao J; Lowery FJ; Zhang Q; Huang WC; Li P; Li M; Wang X; Zhang C; Wang H; Ellis K; Cheerathodi M; McCarty JH; Palmieri D; Saunus J; Lakhani S; Huang S; Sahin AA; Aldape KD; Steeg PS; Yu D
    Nature; 2015 Nov; 527(7576):100-104. PubMed ID: 26479035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking Down Response and Resistance to TRK Inhibitors.
    Okimoto RA; Bivona TG
    Cancer Discov; 2016 Jan; 6(1):14-6. PubMed ID: 26747892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [When gliomes go hand in hand with exosomes].
    Larsen CJ
    Bull Cancer; 2016 Mar; 103(3):222-3. PubMed ID: 26902155
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathology: commonly monitored glioblastoma markers: EFGR, EGFRvIII, PTEN, and MGMT.
    Camara-Quintana JQ; Nitta RT; Li G
    Neurosurg Clin N Am; 2012 Apr; 23(2):237-46, viii. PubMed ID: 22440867
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.